In an industry built on the ability to mimic human behavior, the conversation around neurodivergence has long been relegated ...

A think tank report reveals spending on ADHD services is estimated to reach £314m by April 2026 - more than double the annual ...

Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengthsTwo differentiated treatments exemplify ...

Beyond the Hashtag: Why Self-Diagnosis Misses the Mark features insights from Danielle Moreggi, Clinical Psychologist of Las Vegas, NV, in HelloNation.

German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...

Pregnant women should never consume alcohol because of the high risks to their babies and themselves. According to the ...

A new study published by Current Neuropharmacology reports that CBD-rich cannabis oil can help reduce attention deficit ...

A new study found that social media is causing kids’ attention to drop. Researchers at the Karolinska Institute in Sweden and ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects how the brain regulates ...

Breastfeeding during the first 4 months of life is linked to reduced emotional and behavioural problems in preschoolers; however, benefits beyond 8 months are limited.

This is part 2 of 5 on modern perspectives on ADHD. Part 1: 'Does ADHD Even Exist' is available here. Source: Tara Winstead/Pexels What is ADHD? ADHD is diagnosed ...

WASHINGTON, Dec 18 (Reuters) - Two Democratic lawmakers on Thursday raised concerns about EchoStar's deals to sell key spectrum to AT&T and SpaceX for $40 billion, saying it could shrink competition ...